Joshua Maxey

Co-founder, Managing Director at Third Bridge and 1 other company
On the record
Represented by:
Share profile 

Joshua Maxey is a co-founder and current chief marketing officer at Third Bridge, one of the world’s leading independent research providers serving hedge funds, private equity, mutual funds and management consultants. Joshua has been an integral part of the company’s executive team since its inception, building a global sales team from zero to 100 as the company expanded from its London headquarters to eight offices across three continents and employing over 1,000 staff. Now, as CMO, Joshua is overseeing a global team responsible for raising the profile of one of the largest disruptors in traditional research and has been integral in building up a new strategic marketing and sales function in Europe, China and the US. Prior to Third Bridge, Joshua was in venture capital at Fidelity Ventures and TMT equity research at firms such as Gerson Lehrman Group, Goldman Sachs and Bank of America. Joshua earned his Ph.D. from the University of Bath and is a CFA charter holder.

Recent Quotes
Sign up to view all
  • Joshua Maxey, managing director of Third Bridge, an independent research provider, described the FCA’s conclusions as “troublesome” and “very short-sighted”.

    “I would encourage the FCA to further scrutinise the so-called ‘peppercorn pricing’ many larger sellside houses are deploying, where they are charging nominal fees for research and dumping the costs in other services,” said Mr Maxey. “This is putting unequal pressure on the independent research firms who cannot compete with those economics, and in turn is reducing the overall quality of research available to investors.”

  • The news from UBS this week is something I expect to see continue in large investment banks, particularly in equity trading and research. The regulatory environment and push for transparency in research costs with MiFID II have led to the buy-side reevaluating their research needs, which has further exposed the oversupply of sell-side research in the industry. This market correction has been on the horizon for a while and long overdue.

  • The costs of research packages offered by some of the big banks are totally out of whack with pricing elsewhere in the market.

Sign up to view all